Sporadic inclusion body myositis: The genetic contributions to the pathogenesis

24Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Sporadic inclusion body myositis (sIBM) is the commonest idiopathic inflammatory muscle disease in people over 50 years old. It is characterized by slowly progressive muscle weakness and atrophy, with typical pathological changes of inflammation, degeneration and mitochondrial abnormality in affected muscle fibres. The cause(s) of sIBM are still unknown, but are considered complex, with the contribution of multiple factors such as environmental triggers, ageing and genetic susceptibility. This review summarizes the current understanding of the genetic contributions to sIBM and provides some insights for future research in this mysterious disease with the advantage of the rapid development of advanced genetic technology. An international sIBM genetic study is ongoing and whole-exome sequencing will be applied in a large cohort of sIBM patients with the aim of unravelling important genetic risk factors for sIBM. © 2014 Gang et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Gang, Q., Bettencourt, C., Machado, P., Hanna, M. G., & Houlden, H. (2014, June 19). Sporadic inclusion body myositis: The genetic contributions to the pathogenesis. Orphanet Journal of Rare Diseases. BioMed Central Ltd. https://doi.org/10.1186/1750-1172-9-88

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free